Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huachansu & Gemcitabine in Pancreatic Cancer
NCT00837239Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2007
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cinobufacini in pancreatic cancer (PC), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2007; status: completed.
02
Drugs
cinobufacini
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00837239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837239.